System for setting programmable parameters for an implantable hypertension treatment device
AssigneeCVRx, Inc.
InventorMartin A. Rossing
Life of this patent
Estimating the term…
Loading patent…
AssigneeCVRx, Inc.
InventorMartin A. Rossing
Estimating the term…
A real time, heart rate monitor and a hemodynamic monitoring system are operably integrated with the programmer system for an implantable hypertension treatment device. A series of tests are automatically performed to set programmable parameters for the implantable hypertension treatment device without clinician intervention. In one embodiment, a predetermined level of a dose-response evaluation is initiated for each test in the series. Preferably, the programmer system monitors the heart rate to determine whether a hemodynamic measurement should be initiated at all for a given test, as well as whether the hemodynamic measurement should be initiated earlier or later than a predetermined settling period for assessing the sympathetic nervous response to the test dose. In one embodiment, this determination is based on heart rate stability/instability. Alternatively, other indicators of sympathetic/parasympathetic tone, such as heart rate variability, may be used to trigger/delay the timing of the hemodynamic measurement.
A system for setting programmable parameters for an implantable hypertension treatment device in a patient comprising:
A method of establishing programmable parameters for an implantable hypertension treatment device in a patient comprising:
A method of conducting an electrotherapy dose response test for purposes of setting at least one operating parameter of an implantable hypertension treatment device by using a programming system to automatically perform the steps of:
Dependencies are inferred from the claim text.